Literature DB >> 26461032

Resection of Late Pulmonary Metastases from Pancreatic Adenocarcinoma: Is Surgery an Option?

Bertrand Brieau1, Maximilien Barret1, Alexandre Rouquette2, Johann Dréanic1, Catherine Brezault1, Jean François Regnard3, Romain Coriat1,4.   

Abstract

Patients with recurrences from pancreas adenocarcinoma have a poor survival rate despite new chemotherapy treatment options. Recurrences are mainly hepatic metastases or peritoneal dissemination and surgical treatment is not recommended. Late and single metachronous pulmonary recurrences are uncommon and may mimic primary lung carcinoma. We report two patients with late and unique pulmonary metastasis from pancreatic cancer. These two patients underwent surgical resection; three and five years later, they did not experience recurrences. Cases called for a surgical approach in late and unique pulmonary metastases from pancreatic cancer, and paved the way for a prolonged chemotherapy free period.

Entities:  

Keywords:  Late and unique metastasis; Lung recurrence; Pancreatic cancer; Prolonged survival; Surgical management

Mesh:

Year:  2015        PMID: 26461032     DOI: 10.3109/07357907.2015.1080831

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  6 in total

1.  Primary Recurrence in the Lung is Related to Favorable Prognosis in Patients with Pancreatic Cancer and Postoperative Recurrence.

Authors:  Biao Zheng; Kenoki Ohuchida; Zilong Yan; Takashi Okumura; Takao Ohtsuka; Masafumi Nakamura
Journal:  World J Surg       Date:  2017-11       Impact factor: 3.352

2.  Long-term survival after repeated resection of metachronous lung metastases from pStage IA pancreatic adenocarcinoma.

Authors:  Mamoru Miyasaka; Takehiro Noji; Kazuto Ohtaka; Ryohei Chiba; Shoki Sato; Yasuhito Shoji; Ryunosuke Hase; Tatsunosuke Ichimura; Satoshi Hirano; Naoto Senmaru
Journal:  Clin J Gastroenterol       Date:  2017-10-16

3.  Heterogeneity of metastatic pancreatic adenocarcinoma: Lung metastasis show better prognosis than liver metastasis-a case control study.

Authors:  Claire Decoster; Marine Gilabert; Aurélie Autret; Olivier Turrini; Sandrine Oziel-Taieb; Flora Poizat; Marc Giovannini; Patrice Viens; Juan Iovanna; Jean-Luc Raoul
Journal:  Oncotarget       Date:  2016-07-19

4.  Resection for Pancreatic Cancer Lung Metastases.

Authors:  Masayuki Okui; Takashi Yamamichi; Ayaka Asakawa; Masahiko Harada; Hirotoshi Horio
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2017-10-05

Review 5.  Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature.

Authors:  Martin Lovecek; Pavel Skalicky; Josef Chudacek; Marek Szkorupa; Hana Svebisova; Radmila Lemstrova; Jiri Ehrmann; Bohuslav Melichar; Tharani Yogeswara; Dusan Klos; Radek Vrba; Roman Havlik; Beatrice Mohelnikova-Duchonova
Journal:  World J Gastroenterol       Date:  2017-09-21       Impact factor: 5.742

6.  Significance of pulmonary resection in patients with metachronous pulmonary metastasis from pancreatic ductal adenocarcinoma: a retrospective cohort study.

Authors:  Taro Mashiko; Akira Nakano; Yoshihito Masuoka; Seiichiro Yamamoto; Soji Ozawa; Toshio Nakagohri
Journal:  BMC Surg       Date:  2021-05-05       Impact factor: 2.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.